InsiderClue
← All stocks

ALNYLAM PHARMACEUTICALS, INC.

ALNY Net selling
CIK 0001178670 #636 in the set updated 18 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$53.75M
$10.77M on a plan · $19.78M straight out of an exercise
Sold at will
$23.20M
190 of 343 sales
Net
−$53.75M
−$23.20M against sales at will

By person

20 insiders · 348 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Greenstreet Yvonne
Chief Executive Officer
—
$24.46M (72)
−$24.46M
95,695
0.0715%
$28.96M
+30.3%
Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
—
$10.74M (78) scheduled
−$10.74M
20,569
0.0154%
$6.23M
+59.7%
Garg Pushkal
EVP Chief R&D
—
$8.12M (70) scheduled
−$8.12M
18,693
0.0140%
$5.66M
+19.8%
Poulton Jeffrey V.
EVP, Chief Financial Officer
—
$4.95M (52)
−$4.95M
61,805
0.0462%
$18.71M
+113.9%
Tanguler Tolga
EVP, Chief Commercial Officer
—
$3.06M (52)
−$3.06M
34,297
0.0256%
$10.38M
+194.1%
McLaughlin Melissa
Chief Human Resources Officer
—
$1.27M (14) scheduled
−$1.27M
9,443
0.0071%
$2.86M
−29.3%
PYOTT DAVID E I
Director
—
$1.15M (5) scheduled
−$1.15M
1,582
0.0012%
$478.79K
+1,063%
SCHULMAN AMY W
Director
—
—
—
24,049
0.0180%
$7.28M
+185.1%
BONNEY MICHAEL W
Director
—
—
—
16,804
0.0126%
$5.09M
+4.8%
SUPRAN BRYAN
EVP, CLO and Secretary
—
—
—
14,565
0.0109%
$4.41M
—
Hesslein Robert W.
EVP, CLO and Secretary
—
—
—
8,002
0.0060%
$2.42M
—
HAMBURG MARGARET A
Director
—
—
—
1,582
0.0012%
$478.79K
+1,063%
Ausiello Dennis A
Director
—
—
—
1,582
0.0012%
$478.79K
+1,063%
BRANDICOURT OLIVIER
Director
—
—
—
1,446
0.0011%
$437.63K
—
Sigal Charles Elliott
Director
—
—
—
1,446
0.0011%
$437.63K
—
Reitan Colleen F
Director
—
—
—
1,446
0.0011%
$437.63K
+4,419%
KELLOGG PETER N
Director
—
—
—
1,446
0.0011%
$437.63K
—
Bertozzi Carolyn R
Director
—
—
—
775
0.0006%
$234.55K
—
Arbuckle Stuart A
Director
—
—
—
671
0.0005%
$203.08K
—
SHARP PHILLIP A
Director
—
—
—
0
0.0000%
$0.00
—

Individual transactions

10
Insider
Date
Role
Action
Shares
Price
Amount
PYOTT DAVID E I
1 Jun 2026
Director
Sold after exercise
17
$302.65
$5.15K
PYOTT DAVID E I
1 Jun 2026
Director
Sold after exercise
495
$300.72
$148.86K
PYOTT DAVID E I
1 Jun 2026
Director
Sold after exercise
1,222
$299.87
$366.44K
PYOTT DAVID E I
1 Jun 2026
Director
Sold after exercise
1,175
$298.91
$351.22K
PYOTT DAVID E I
1 Jun 2026
Director
Sold after exercise
921
$297.71
$274.19K
Garg Pushkal
27 Feb 2026
EVP Chief R&D
Sold after exercise
140
$334.39
$46.81K
Garg Pushkal
27 Feb 2026
EVP Chief R&D
Sold after exercise
942
$332.48
$313.20K
Garg Pushkal
27 Feb 2026
EVP Chief R&D
Sold after exercise
1,159
$331.49
$384.20K
Garg Pushkal
27 Feb 2026
EVP Chief R&D
Sold after exercise
2,259
$330.73
$747.12K
Garg Pushkal
27 Feb 2026
EVP Chief R&D
Sold after exercise
127
$328.92
$41.77K
Showing 250 of 348 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 49
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 112
Sales straight out of an exercise 41
Sales at will 190
Transactions with no price 0
Shares from compensation/vesting 226,470
History held since 21 Sep 2016